Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela J Higgins

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Cancers|March 28, 2024
Multimodal, Technology-Assisted Intervention for the Management of Menopause after Cancer Improves Cancer-Related Quality of Life-Results from the Menopause after Cancer (Mac) StudyFionán Donohoe, Yvonne O'Meara, Aidin Roberts, et al.
The Oncologist|April 25, 2014
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarateAmir T Fathi, Hossein Sadrzadeh, Amy H Comander, et al.
Irish Journal of Medical Science|January 15, 2021
Virtual oncology clinics during the COVID-19 pandemicDavid O'Reilly, Hailey Carroll, Mairi Lucas, et al.
Irish Journal of Medical Science|May 28, 2024
The impact of expanded access programs for systemic anticancer therapy in an Irish cancer centreTimothy K Cronin, Cian Ronayne, Niamh O'Donovan, et al.
Cancer Biology & Therapy|December 3, 2010
PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cellsMichaela J Higgins, Julia A Beaver, Hong Yuen Wong, et al.
The Oncologist|May 12, 2021
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
Journal of the National Cancer Institute|March 20, 2018
Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27Kathrin Strasser-Weippl, Michaela J Higgins, Judith-Anne W Chapman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Knockin of mutant PIK3CA activates multiple oncogenic pathwaysJohn P Gustin, Bedri Karakas, Michele B Weiss, et al.
The Oncologist|October 30, 2016
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
Nature Medicine|December 9, 2024
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trialNadia Harbeck, Eva Ciruelos, Guy Jerusalem, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Cancers|March 28, 2024
Multimodal, Technology-Assisted Intervention for the Management of Menopause after Cancer Improves Cancer-Related Quality of Life-Results from the Menopause after Cancer (Mac) StudyFionán Donohoe, Yvonne O'Meara, Aidin Roberts, et al.
The Oncologist|April 25, 2014
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarateAmir T Fathi, Hossein Sadrzadeh, Amy H Comander, et al.
Irish Journal of Medical Science|January 15, 2021
Virtual oncology clinics during the COVID-19 pandemicDavid O'Reilly, Hailey Carroll, Mairi Lucas, et al.
Irish Journal of Medical Science|May 28, 2024
The impact of expanded access programs for systemic anticancer therapy in an Irish cancer centreTimothy K Cronin, Cian Ronayne, Niamh O'Donovan, et al.
Cancer Biology & Therapy|December 3, 2010
PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cellsMichaela J Higgins, Julia A Beaver, Hong Yuen Wong, et al.
The Oncologist|May 12, 2021
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
Journal of the National Cancer Institute|March 20, 2018
Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27Kathrin Strasser-Weippl, Michaela J Higgins, Judith-Anne W Chapman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Knockin of mutant PIK3CA activates multiple oncogenic pathwaysJohn P Gustin, Bedri Karakas, Michele B Weiss, et al.
The Oncologist|October 30, 2016
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
Nature Medicine|December 9, 2024
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trialNadia Harbeck, Eva Ciruelos, Guy Jerusalem, et al.
Pageof 5